346 related articles for article (PubMed ID: 28973440)
1. MAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter.
Álvaro-Blanco J; Urso K; Chiodo Y; Martín-Cortázar C; Kourani O; Arco PG; Rodríguez-Martínez M; Calonge E; Alcamí J; Redondo JM; Iglesias T; Campanero MR
Nucleic Acids Res; 2017 Sep; 45(17):9960-9975. PubMed ID: 28973440
[TBL] [Abstract][Full Text] [Related]
2. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
[TBL] [Abstract][Full Text] [Related]
3. A B-myb promoter corepressor site facilitates in vivo occupation of the adjacent E2F site by p107 x E2F and p130 x E2F complexes.
Catchpole S; Tavner F; Le Cam L; Sardet C; Watson RJ
J Biol Chem; 2002 Oct; 277(41):39015-24. PubMed ID: 12147683
[TBL] [Abstract][Full Text] [Related]
4. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
Nakajima Y
Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
[TBL] [Abstract][Full Text] [Related]
5. E2Fs link the control of G1/S and G2/M transcription.
Zhu W; Giangrande PH; Nevins JR
EMBO J; 2004 Nov; 23(23):4615-26. PubMed ID: 15510213
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element.
Liu N; Lucibello FC; Zwicker J; Engeland K; Müller R
Nucleic Acids Res; 1996 Aug; 24(15):2905-10. PubMed ID: 8760872
[TBL] [Abstract][Full Text] [Related]
7. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
Bennett JD; Farlie PG; Watson RJ
Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
[TBL] [Abstract][Full Text] [Related]
8. Interaction of E2F-Rb family members with corepressors binding to the adjacent E2F site.
Nakajima Y; Yamada S; Kamata N; Ikeda MA
Biochem Biophys Res Commun; 2007 Dec; 364(4):1050-5. PubMed ID: 17976373
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the retinoblastoma-E2F pathway by the ubiquitin-proteasome system.
Sengupta S; Henry RW
Biochim Biophys Acta; 2015 Oct; 1849(10):1289-97. PubMed ID: 26319102
[TBL] [Abstract][Full Text] [Related]
10. Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes.
Korenjak M; Taylor-Harding B; Binné UK; Satterlee JS; Stevaux O; Aasland R; White-Cooper H; Dyson N; Brehm A
Cell; 2004 Oct; 119(2):181-93. PubMed ID: 15479636
[TBL] [Abstract][Full Text] [Related]
11. Distinct cellular factors regulate the c-myb promoter through its E2F element.
Campanero MR; Armstrong M; Flemington E
Mol Cell Biol; 1999 Dec; 19(12):8442-50. PubMed ID: 10567569
[TBL] [Abstract][Full Text] [Related]
12. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
13. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription.
Lam EW; Watson RJ
EMBO J; 1993 Jul; 12(7):2705-13. PubMed ID: 8334989
[TBL] [Abstract][Full Text] [Related]
14. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
15. Selective ablation of retinoblastoma protein function by the RET finger protein.
Krützfeldt M; Ellis M; Weekes DB; Bull JJ; Eilers M; Vivanco MD; Sellers WR; Mittnacht S
Mol Cell; 2005 Apr; 18(2):213-24. PubMed ID: 15837424
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG
J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185
[TBL] [Abstract][Full Text] [Related]
17. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
[TBL] [Abstract][Full Text] [Related]
18. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.
Le Cam L; Polanowska J; Fabbrizio E; Olivier M; Philips A; Ng Eaton E; Classon M; Geng Y; Sardet C
EMBO J; 1999 Apr; 18(7):1878-90. PubMed ID: 10202151
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
[TBL] [Abstract][Full Text] [Related]
20. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
Oswald F; Lovec H; Möröy T; Lipp M
Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
